Genome sequence reveals enzymes for meloxicam degradation in Gordonia alkanivorans, indicating its potential for bioremediation.
We report the draft genome sequence of Gordonia alkanivorans IEGM 1277, an actinomycete strain exhibiting a pronounced ability to degrade the pharmaceutical pollutant meloxicam—an emerging environmental contaminant. Utilizing the acquired sequence, identify candidate genes that encode enzymes implicated in the degradation of meloxicam.
No takes yet. Share an insight, caveat, or question.
Tyan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: